PDA+: A Personal Digital Assistant for Obesity Treatment - an RCT testing the use of technology to enhance weight loss treatment for veterans.
PDA+: A Personal Digital Assistant for Obesity Treatment - an RCT testing the use of technology to enhance weight loss treatment for veterans.
复制标题
PDA+：肥胖治疗的个人数字助手 - RCT测试使用技术来增强退伍军人的减肥治疗。
DOI：
10.1186/1471-2458-11-223
复制
发表时间：
2011-04-11
影响因子：
4.5
通讯作者：
Spring B
中科院分区：
文献类型：
--
作者：
Duncan JM;Janke EA;Kozak AT;Roehrig M;Russell SW;McFadden HG;Demott A;Pictor A;Hedeker D;Spring B
肥胖的成年人很难做出必要的改变来实现即使是适度的减肥，尽管体重减少10%也会对健康有显著的好处。未能实现减肥目标可能在一定程度上与肥胖治疗的障碍有关。循证肥胖治疗的广泛传播面临着成本、可及性和大规模实施方案特征等多重挑战。PDA+：一项用于肥胖治疗的个人数字助理随机对照试验（RCT）旨在测试基于PDA的行为干预是否能增强VA医疗中心管理超重/肥胖退伍军人的现有团体减肥治疗计划的有效性。我们还旨在引入技术，以克服传统肥胖治疗的系统性障碍。退伍军人报名参加MOVE!将招募Hines Hospital VAMC的BMI ≥ 25且≤ 40且体重<400磅、经历慢性疼痛（入组前NRS-I量表≥ 4且≥ 6个月）且能够参加中等强度运动计划的患者，并筛选合格性。受试者将随机接受：a）MOVE!单独治疗（标准护理）或B）标准护理加PDA（PDA+）。随机分配至PDA+组的受试者将在PDA上记录饮食摄入量、体力活动和体重。此外，他们还将记录情绪和疼痛强度，并在12个月研究的前6个月接受两周一次的电话支持。所有参与者将每三个月参加一次面对面的实验室会议，以完成问卷调查和收集拟人化数据。体重减轻和疼痛程度降低是主要结局。PDA+试验是了解如何改善肥胖治疗技术使用的重要一步。该试验将通过实施减肥干预的有效行为成分和提供高强度，低成本的肥胖治疗来解决肥胖治疗的障碍。这项随机对照试验还测试了一种由手持技术支持的干预方法，该方法适用于传统上被认为技术素养水平较低的人群。ClinicalTrials.gov
Obese adults struggle to make the changes necessary to achieve even modest weight loss, though a decrease in weight by as little as 10% can have significant health benefits. Failure to meet weight loss goals may in part be associated with barriers to obesity treatment. Wide-spread dissemination of evidence-based obesity treatment faces multiple challenges including cost, access, and implementing the programmatic characteristics on a large scale. The PDA+: A Personal Digital Assistant for Obesity Treatment randomized controlled trial (RCT) was designed to test whether a PDA-based behavioral intervention enhances the effectiveness of the existing group weight loss treatment program at VA Medical Centers Managing Overweight/Obese Veterans Everywhere (MOVE!). We also aim to introduce technology as a way to overcome systemic barriers of traditional obesity treatment. Veterans enrolled in the MOVE! group at the Hines Hospital VAMC with BMI ≥ 25 and ≤ 40 and weigh < 400 pounds, experience chronic pain (≥ 4 on the NRS-I scale for ≥ 6 months prior to enrollment) and are able to participate in a moderate intensity exercise program will be recruited and screened for eligibility. Participants will be randomized to receive either: a) MOVE! treatment alone (Standard Care) or b) Standard Care plus PDA (PDA+). Those randomized to PDA+ will record dietary intake, physical activity, and weight on the PDA. In addition, they will also record mood and pain intensity, and receive biweekly telephone support for the first 6-months of the 12-month study. All participants will attend in-person lab sessions every three months to complete questionnaires and for the collection of anthropomorphic data. Weight loss and decrease in pain level intensity are the primary outcomes. The PDA+ trial represents an important step in understanding ways to improve the use of technology in obesity treatment. The trial will address barriers to obesity care by implementing effective behavioral components of a weight loss intervention and delivering high intensity, low cost obesity treatment. This RCT also tests an intervention approach supported by handheld technology in a population traditionally considered to have lower levels of technology literacy. ClinicalTrials.gov: NCT00371462
登录
查看更多内容
影响因子：
2.2
作者：
Burke LE;Styn MA;Glanz K;Ewing LJ;Elci OU;Conroy MB;Sereika SM;Acharya SD;Music E;Keating AL;Sevick MA
通讯作者：
Sevick MA
DOI：
10.3102/10769986024001070
发表时间：
1999-03-01
影响因子：
2.4
作者：
Hedeker, D;Gibbons, RD;Waternaux, C
通讯作者：
Waternaux, C
影响因子：
3.6
作者：
Chrubasik, S;Junck, H;Stutzke, O
通讯作者：
Stutzke, O
影响因子：
--
作者：
Helsel, Diane L.;Jakicic, John M.;Otto, Amy D.
通讯作者：
Otto, Amy D.
影响因子：
7.4
作者：
Farrar, JT;Young, JP;Poole, RM
通讯作者：
Poole, RM